Skip to main content
Erschienen in: European Radiology 9/2020

20.04.2020 | Breast

Effect of neoadjuvant chemotherapy on breast tissue composition: a longitudinal mammographic study with automated volumetric measurement

verfasst von: Hyeon Jun Jang, Hye Jung Kim, Yee Soo Chae, Soo Jung Lee, See Hyung Kim, Hoseok Lee, Won Hwa Kim

Erschienen in: European Radiology | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate the effect of neoadjuvant chemotherapy (NAC) on breast tissue composition with mammographic automated volumetric measurement.

Methods

This retrospective study included 168 breast cancer patients who were treated with NAC and underwent serial mammography (pre-treatment, mid-treatment, and post-treatment) between January 2015 and October 2018. Automated volumetric measurements of the contralateral breast volume (BV), fibroglandular volume (FGV), and breast density (BD) were performed using Volpara software. BD grades were divided into 4 groups by Volpara density grade (VDG). The longitudinal changes in BV, FGV, BD, and their associated factors were evaluated.

Results

Repeated-measures analysis of variance demonstrated a significant reduction in BV, FGV, and BD over time (p < 0.001, p < 0.001, and p = 0.002, respectively). BV showed a greater reduction in the second half than in the first half (− 28.6 cm3 vs. − 15.2 cm3), BD showed a greater reduction in the first half than in the second half (− 0.8% vs. − 0.1%), and FGV steadily decreased (− 4.6 cm3 and − 3.9 cm3 in the first and second halves). On multivariable linear regression analysis, chemotherapy regimen was associated with BV change between pre- and post-treatment (p = 0.002); age (p = 0.024) and VDG (p = 0.027) were associated with FGV change; age (p = 0.037), VDG (p = 0.002), and chemotherapy regimen (p = 0.003) were associated with BD change.

Conclusions

NAC affects breast tissue composition, reflected as reductions in BV, FGV, and BD. Mammography with automated volumetric measurement can capture quantitative changes in these breast tissue parameters during NAC.

Key Points

• Neoadjuvant chemotherapy (NAC) affects breast tissue composition with different patterns of reduction in breast volume, fibroglandular volume, and breast density.
• Age, Volpara density grades, and NAC regimen were independent factors associated with breast density change between pre-treatment and post-treatment.
• Mammography with automated volumetric measurement enables identification of longitudinal changes in breast tissue composition.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Fisher B, Bryant J, Wolmark N et al (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672–2685CrossRef Fisher B, Bryant J, Wolmark N et al (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672–2685CrossRef
2.
Zurück zum Zitat Fowler AM, Mankoff DA, Joe BN (2017) Imaging neoadjuvant therapy response in breast cancer. Radiology 285:358–375CrossRef Fowler AM, Mankoff DA, Joe BN (2017) Imaging neoadjuvant therapy response in breast cancer. Radiology 285:358–375CrossRef
3.
Zurück zum Zitat Helvie MA, Joynt LK, Cody RL, Pierce LJ, Adler DD, Merajver SD (1996) Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology 198:327–332CrossRef Helvie MA, Joynt LK, Cody RL, Pierce LJ, Adler DD, Merajver SD (1996) Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology 198:327–332CrossRef
4.
Zurück zum Zitat Rauch GM, Adrada BE, Kuerer HM, van la Parra RF, Leung JW, Yang WT (2017) Multimodality imaging for evaluating response to neoadjuvant chemotherapy in breast cancer. AJR Am J Roentgenol 208:290–299CrossRef Rauch GM, Adrada BE, Kuerer HM, van la Parra RF, Leung JW, Yang WT (2017) Multimodality imaging for evaluating response to neoadjuvant chemotherapy in breast cancer. AJR Am J Roentgenol 208:290–299CrossRef
5.
Zurück zum Zitat Fornier MN, Modi S, Panageas KS, Norton L, Hudis C (2005) Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer 104:1575–1579CrossRef Fornier MN, Modi S, Panageas KS, Norton L, Hudis C (2005) Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer 104:1575–1579CrossRef
6.
Zurück zum Zitat Poikonen P, Saarto T, Elomaa I, Joensuu H, Blomqvist C (2000) Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients. Eur J Cancer 36:43–48CrossRef Poikonen P, Saarto T, Elomaa I, Joensuu H, Blomqvist C (2000) Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients. Eur J Cancer 36:43–48CrossRef
7.
Zurück zum Zitat Chen JH, Nie K, Bahri S et al (2010) Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation. Radiology 255:44–52CrossRef Chen JH, Nie K, Bahri S et al (2010) Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation. Radiology 255:44–52CrossRef
8.
Zurück zum Zitat Chen JH, Pan WF, Kao J et al (2013) Effect of taxane-based neoadjuvant chemotherapy on fibroglandular tissue volume and percent breast density in the contralateral normal breast evaluated by 3T MR. NMR Biomed 26:1705–1713CrossRef Chen JH, Pan WF, Kao J et al (2013) Effect of taxane-based neoadjuvant chemotherapy on fibroglandular tissue volume and percent breast density in the contralateral normal breast evaluated by 3T MR. NMR Biomed 26:1705–1713CrossRef
9.
Zurück zum Zitat Jeffreys M, Warren R, Highnam R, Smith GD (2006) Initial experiences of using an automated volumetric measure of breast density: the standard mammogram form. Br J Radiol 79:378–382CrossRef Jeffreys M, Warren R, Highnam R, Smith GD (2006) Initial experiences of using an automated volumetric measure of breast density: the standard mammogram form. Br J Radiol 79:378–382CrossRef
10.
Zurück zum Zitat Teo I, Whelehan P, Macaskill JE, Vinnicombe S, Munnoch DA, Evans A (2016) Volpara as a measurement tool for breast volume. J Plast Reconstr Aesthet Surg 69:581–582CrossRef Teo I, Whelehan P, Macaskill JE, Vinnicombe S, Munnoch DA, Evans A (2016) Volpara as a measurement tool for breast volume. J Plast Reconstr Aesthet Surg 69:581–582CrossRef
11.
Zurück zum Zitat Telli ML, Gradishar WJ, Ward JH (2019) NCCN guidelines updates: breast cancer. J Natl Compr Canc Netw 17:552–555PubMed Telli ML, Gradishar WJ, Ward JH (2019) NCCN guidelines updates: breast cancer. J Natl Compr Canc Netw 17:552–555PubMed
12.
Zurück zum Zitat Destounis S, Johnston L, Highnam R, Arieno A, Morgan R, Chan A (2017) Using volumetric breast density to quantify the potential masking risk of mammographic density. AJR Am J Roentgenol 208:222–227CrossRef Destounis S, Johnston L, Highnam R, Arieno A, Morgan R, Chan A (2017) Using volumetric breast density to quantify the potential masking risk of mammographic density. AJR Am J Roentgenol 208:222–227CrossRef
13.
Zurück zum Zitat Persson I, Thurfjell E, Holmberg L (1997) Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol 15:3201–3207CrossRef Persson I, Thurfjell E, Holmberg L (1997) Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol 15:3201–3207CrossRef
14.
Zurück zum Zitat Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L (1995) Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 196:433–437CrossRef Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L (1995) Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 196:433–437CrossRef
15.
Zurück zum Zitat Cuzick J, Warwick J, Pinney E et al (2011) Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 103:744–752CrossRef Cuzick J, Warwick J, Pinney E et al (2011) Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 103:744–752CrossRef
16.
Zurück zum Zitat Kim WH, Cho N, Kim YS, Yi A (2018) Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer. Eur Radiol 28:3176–3184CrossRef Kim WH, Cho N, Kim YS, Yi A (2018) Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer. Eur Radiol 28:3176–3184CrossRef
17.
Zurück zum Zitat Li J, Humphreys K, Eriksson L, Edgren G, Czene K, Hall P (2013) Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. J Clin Oncol 31:2249–2256CrossRef Li J, Humphreys K, Eriksson L, Edgren G, Czene K, Hall P (2013) Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. J Clin Oncol 31:2249–2256CrossRef
18.
Zurück zum Zitat Boussios S, Pentheroudakis G, Katsanos K, Pavlidis N (2012) Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management. Ann Gastroenterol 25:106–118PubMedPubMedCentral Boussios S, Pentheroudakis G, Katsanos K, Pavlidis N (2012) Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management. Ann Gastroenterol 25:106–118PubMedPubMedCentral
19.
Zurück zum Zitat Wanders JO, Bakker MF, Veldhuis WB, Peeters PH, van Gils CH (2015) The effect of weight change on changes in breast density measures over menopause in a breast cancer screening cohort. Breast Cancer Res 17:74CrossRef Wanders JO, Bakker MF, Veldhuis WB, Peeters PH, van Gils CH (2015) The effect of weight change on changes in breast density measures over menopause in a breast cancer screening cohort. Breast Cancer Res 17:74CrossRef
20.
Zurück zum Zitat Aktepe F, Kapucuoglu N, Pak I (1996) The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer. Histopathology 29:63–67CrossRef Aktepe F, Kapucuoglu N, Pak I (1996) The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer. Histopathology 29:63–67CrossRef
21.
Zurück zum Zitat Moll UM, Chumas J (1997) Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer. Pathol Res Pract 193:187–196CrossRef Moll UM, Chumas J (1997) Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer. Pathol Res Pract 193:187–196CrossRef
22.
Zurück zum Zitat Nyante SJ, Sherman ME, Pfeiffer RM et al (2015) Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer. J Natl Cancer Inst 107 Nyante SJ, Sherman ME, Pfeiffer RM et al (2015) Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer. J Natl Cancer Inst 107
23.
Zurück zum Zitat Ko KL, Shin IS, You JY, Jung SY, Ro J, Lee ES (2013) Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients. Breast Cancer Res Treat 142:559–567CrossRef Ko KL, Shin IS, You JY, Jung SY, Ro J, Lee ES (2013) Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients. Breast Cancer Res Treat 142:559–567CrossRef
24.
Zurück zum Zitat Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP, Chinnaiyan AM (2003) Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res 63:132–139PubMed Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP, Chinnaiyan AM (2003) Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res 63:132–139PubMed
25.
Zurück zum Zitat Menendez JA, Vellon L, Mehmi I et al (2004) Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proc Natl Acad Sci U S A 101:10715–10720CrossRef Menendez JA, Vellon L, Mehmi I et al (2004) Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proc Natl Acad Sci U S A 101:10715–10720CrossRef
26.
Zurück zum Zitat Wu S, Weinstein SP, Conant EF, Kontos D (2013) Automated fibroglandular tissue segmentation and volumetric density estimation in breast MRI using an atlas-aided fuzzy C-means method. Med Phys 40:122302CrossRef Wu S, Weinstein SP, Conant EF, Kontos D (2013) Automated fibroglandular tissue segmentation and volumetric density estimation in breast MRI using an atlas-aided fuzzy C-means method. Med Phys 40:122302CrossRef
27.
Zurück zum Zitat Kim WH, Moon WK, Kim SM et al (2013) Variability of breast density assessment in short-term reimaging with digital mammography. Eur J Radiol 82:1724–1730CrossRef Kim WH, Moon WK, Kim SM et al (2013) Variability of breast density assessment in short-term reimaging with digital mammography. Eur J Radiol 82:1724–1730CrossRef
28.
Zurück zum Zitat Sandberg ME, Li J, Hall P et al (2013) Change of mammographic density predicts the risk of contralateral breast cancer--a case-control study. Breast Cancer Res 15:R57CrossRef Sandberg ME, Li J, Hall P et al (2013) Change of mammographic density predicts the risk of contralateral breast cancer--a case-control study. Breast Cancer Res 15:R57CrossRef
Metadaten
Titel
Effect of neoadjuvant chemotherapy on breast tissue composition: a longitudinal mammographic study with automated volumetric measurement
verfasst von
Hyeon Jun Jang
Hye Jung Kim
Yee Soo Chae
Soo Jung Lee
See Hyung Kim
Hoseok Lee
Won Hwa Kim
Publikationsdatum
20.04.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 9/2020
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-06830-9

Weitere Artikel der Ausgabe 9/2020

European Radiology 9/2020 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.